Close
Help


Emerging Therapeutic Options for the Management of COPD

Posted Wed, Apr, 10,2013

Published today in Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine is a new review by Debra J. Reid and Nga T. Pham.  Read more about this paper below:

Title

Emerging Therapeutic Options for the Management of COPD

Abstract

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is projected to be the third by 2020. COPD is characterized by chronic airflow limitation caused by airway inflammation and parenchymal destruction that is usually progressive. Inhaled bronchodilators continue to be the mainstay of the current management of COPD. Safety and efficacy data of the recently approved medications including aclidinium, glycopyrronium, roflumilast, and indacaterol are reviewed here.

Click here to learn more about the article, download it and comment

share on

Posted in: Articles Published

  • Efficient Processing: 4 Weeks Average to First Editorial Decision
  • Fair & Independent Expert Peer Review
  • High Visibility & Extensive Database Coverage
Services for Authors
What Your Colleagues Say About Libertas Academica
This is my second publication with Libertas. I greatly appreciate the attention to details throughout the process, especially the graphical enhancement of my figures. The author interface was very easy to use and the turnaround time on your end was swift and accurate.  I compliment you and your team on your administrative efficiency and high quality of work.
Dr Jimmy T Efird (East Carolina University, Greenville, NC, USA)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube